Physician profile
Katherine D Dronka
NPI 1841643236
$1,609.01
in general payments reported to CMS, 2019-2025
11 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $73.12 · 2021: $81.36 · 2022: $390 · 2024: $104 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $415.43 | 2022-2025 | Infuse, Infuse Multifocal |
| Alcon Vision LLC | $329.76 | 2019-2025 | |
| Coopervision INC. | $235.89 | 2019-2024 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $207.10 | 2019-2022 | |
| Genentech USA, INC. | $132.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $108.62 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $77.26 | 2019 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Dompe US, INC. | $16.54 | 2025 | Oxervate |
| Derma Sciences, INC. | $11.64 | 2019 | |
| Z-Medica, LLC | $8.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Dronka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.